The cannabinoid CB(2) receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence

類似資料

• Positive Allosteric Modulation of CB(1) Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward
  著者:: Slivicki, Richard A., 等
  出版事項: (2020)
• Slowly Signaling G Protein–Biased CB(2) Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence
  著者:: Lin, Xiaoyan, 等
  出版事項: (2018)
• Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit
  著者:: Slivicki, Richard A., 等
  出版事項: (2018)
• Activation of cannabinoid CB(1) and CB(2) receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
  著者:: Rahn, E J, 等
  出版事項: (2007)
• Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain
  著者:: Gutierrez, Tannia, 等
  出版事項: (2011)